Continence Nurses in the US Come to the Aid of Patients for the Management of Urinary Incontinence and Overactive Bladder
Posted on: Thursday, 13 April 2006, 09:01 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c35542) has announced the addition of Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US to their offering.
Urinary incontinence and overactive bladder disorders are estimated to affect more than 10% of the female population. However, presentation, diagnosis and treatments rates are poor. In the US, the employment of Continence Nurses provides an ideal opportunity to ensure that patients are able to gain access to expert advice and treatment.
Scope of this title:
Assessment of the responsibilities of the US Continence Nurse including their role in the referral pathway, diagnosis and prescribing of drug therapy.
Evaluation of reasons influencing patient presentation including educational and marketing campaigns.
Analysis of treatment methods employed, influences on treatment choice and perception of current drug therapies.
Identification of unmet needs and potential drivers of change.
Highlights of this title:
Continence Nurses in the US play a varied role in the management of urinary incontinence and overactive bladder patients, with over two thirds recommending or prescribing pharmacological therapies. Pharmaceutical companies promoting pharmacological therapies in the US should consider Continence Nurses as key targets.
For more than 50% of patients presenting to Continence Nurses, this is the first healthcare professional that the patient will have spoken to about their condition; frequently identified as a direct result of presenting for another condition. Therefore, Continence Nurses are vital to the diagnosis and referral of this subgroup of patients.
Continence Nurses are likely to have more time than other physicians to discuss the nature of symptoms and side effects with patients. By supporting Continence Nurses, pharmaceutical companies could improve patients knowledge of the condition and its treatment, thereby improving treatment retention and switching rates.
Reasons to order your copy:
Understand the role of Continence Nurses in the treatment of urinary incontinence and overactive bladder for strategic product planning and targeting.
Evaluate methods for improving presentation rates and thereby utilization of treatments for urinary incontinence and overactive bladder disorders.
Identify concerns of Continence Nurses and patients regarding current treatment and unmet needs.
For more information visit http://www.researchandmarkets.com/reports/c35542
Source: Datamonitor
Source: Business Wire
Related Articles
- REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder
- Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
- Monitor A Drug Treatment Offering A Greater Reduction In The Number Of UUI Episodes Per Week Than Extended-Release Tolterodine For The Treatment Of Urge Urinary Incontinence
- Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
- Viventia Initiates Patient Treatment in Bladder Cancer Trial
- Enrollment Completed in Post-Market Study of Novasys Medical's Renessa(R) Treatment for Stress Urinary Incontinence
- Newly Presented Data on VESIcare (R) (Solifenacin Succinate) Show Significant Improvements in Urgency for Patients With Overactive Bladder
- Medtronic Receives FDA Approval for InterStim(R) II System for Treatment of Overactive Bladder, Urinary Retention
- Indevus Initiates Phase III Clinical Program for SANCTURA XR(TM) in Overactive Bladder; Indevus Receives $10 Million Milestone Payment From Esprit
- Odyssey Pharmaceuticals and Indevus Pharmaceuticals Announce Odyssey's Plans to Initiate Phase IV Open Label Study of the Effectiveness and Safety of SANCTURA in Patients With Overactive Bladder Symptoms
 |
 |
User Comments (0)
RSS Feeds